Saifer MGP - Search Results

1

Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.

Kelly SJ, Delnomdedieu M, Oliverio MI, Williams LD, Saifer MGP, Sherman MR, Coffman TM, Johnson GA, Hershfield MS. Kelly SJ, et al. Among authors: saifer mgp. J Am Soc Nephrol. 2001 May;12(5):1001-1009. doi: 10.1681/ASN.V1251001. J Am Soc Nephrol. 2001. PMID: 11316859

2

PEG-uricase in the management of treatment-resistant gout and hyperuricemia.

Sherman MR, Saifer MG, Perez-Ruiz F. Sherman MR, et al. Adv Drug Deliv Rev. 2008 Jan 3;60(1):59-68. doi: 10.1016/j.addr.2007.06.011. Epub 2007 Aug 14. Adv Drug Deliv Rev. 2008. PMID: 17826865 Review.

3

Role of the methoxy group in immune responses to mPEG-protein conjugates.

Sherman MR, Williams LD, Sobczyk MA, Michaels SJ, Saifer MG. Sherman MR, et al. Bioconjug Chem. 2012 Mar 21;23(3):485-99. doi: 10.1021/bc200551b. Epub 2012 Mar 7. Bioconjug Chem. 2012. PMID: 22332808 Free PMC article.

4

Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton poly-ethylene glycol.

Saifer MG, Somack R, Williams LD. Saifer MG, et al. Adv Exp Med Biol. 1994;366:377-87. doi: 10.1007/978-1-4615-1833-4_26. Adv Exp Med Biol. 1994. PMID: 7771266

5

Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.

Saifer MG, Williams LD, Sobczyk MA, Michaels SJ, Sherman MR. Saifer MG, et al. Mol Immunol. 2014 Feb;57(2):236-46. doi: 10.1016/j.molimm.2013.07.014. Epub 2013 Nov 5. Mol Immunol. 2014. PMID: 24200843 Free article.

6

Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000-72,000 daltons).

Somack R, Saifer MG, Williams LD. Somack R, et al. Free Radic Res Commun. 1991;12-13 Pt 2:553-62. doi: 10.3109/10715769109145830. Free Radic Res Commun. 1991. PMID: 2060832

7

Pharmacokinetics and tolerability of ventricularly administered superoxide dismutase in monkeys and preliminary clinical observations in familial ALS.

Smith RA, Balis FM, Ott KH, Elsberry DD, Sherman MR, Saifer MG. Smith RA, et al. J Neurol Sci. 1995 May;129 Suppl:13-8. doi: 10.1016/0022-510x(95)00051-3. J Neurol Sci. 1995. PMID: 7595604 Clinical Trial.

8

Bioavailability of superoxide dismutase: implications for the anti-inflammatory action mechanism of orgotein.

Huber W, Menander-Huber KB, Saifer MG, Williams LD. Huber W, et al. Agents Actions Suppl. 1980;7:185-95. Agents Actions Suppl. 1980. PMID: 6454334 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters